Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Summary

The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.

Timeline

Start

2004-08

Primary completion

—

Completion

2005-12

Drugs

Indications